XML 22 R46.htm IDEA: XBRL DOCUMENT v2.4.1.9
Acquisitions and License Agreements (Schedule of Intangible Assets Acquired) (Details) (USD $)
In Millions, unless otherwise specified
0 Months Ended
Aug. 14, 2014
Mar. 19, 2014
Questcor Pharmaceuticals, Inc.    
Intangible Assets Acquired as Part of Business Combination [Line Items]    
Intangible assets acquired $ 5,601.1us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorPharmaceuticalsInc.Member
 
Questcor Pharmaceuticals, Inc. | Trademarks    
Intangible Assets Acquired as Part of Business Combination [Line Items]    
Intangible assets acquired 5.2us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorPharmaceuticalsInc.Member
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksMember
 
Intangible assets acquired, amortization period 13 years  
Questcor Pharmaceuticals, Inc. | Customer Relationships    
Intangible Assets Acquired as Part of Business Combination [Line Items]    
Intangible assets acquired 34.3us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorPharmaceuticalsInc.Member
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember
 
Intangible assets acquired, amortization period 12 years  
H. P. Acthar Gel | Questcor Pharmaceuticals, Inc. | Completed Technology    
Intangible Assets Acquired as Part of Business Combination [Line Items]    
Intangible assets acquired 5,343.3us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorPharmaceuticalsInc.Member
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= mnk_CompletedTechnologyMember
/ us-gaap_ProductOrServiceAxis
= mnk_H.P.ActharGelMember
 
Intangible assets acquired, amortization period 18 years  
Ofirmev | Cadence Pharmaceuticals, Inc. | Completed Technology    
Intangible Assets Acquired as Part of Business Combination [Line Items]    
Intangible assets acquired   1,300.0us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
/ us-gaap_BusinessAcquisitionAxis
= mnk_CadencePharmaceuticalsInc.Member
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= mnk_CompletedTechnologyMember
/ us-gaap_ProductOrServiceAxis
= mnk_OfirmevMember
Intangible assets acquired, amortization period   8 years
In-process Research and Development | Synacthen | Questcor Pharmaceuticals, Inc.    
Intangible Assets Acquired as Part of Business Combination [Line Items]    
Intangible assets acquired, non-amortizable $ 218.3us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorPharmaceuticalsInc.Member
/ us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_InProcessResearchAndDevelopmentMember
/ us-gaap_ProductOrServiceAxis
= mnk_SynacthenMember